A routine biopsy is stained and read to catch structural damage: ulcers, cancer, celiac changes, visible inflammation. It isn’t built to count mast cells or measure how close they sit to nerve endings, and that proximity, not damage, is a documented, separate mechanism for real pain in tissue that reads as completely normal.
The report says normal, and normal is supposed to be the end of the conversation. For a lot of women, it’s the start of a longer, more frustrating one, because the pain or the pattern didn’t get the memo that the tissue looked fine under a microscope. You still know exactly what you felt on the drive home from the procedure, before the results even came back, and a piece of paper saying “normal” doesn’t erase that memory.
Here’s what “normal” actually means in that report, and just as importantly, what it doesn’t rule out. I’ve written elsewhere about what the diagnostic conversation should look like. This one is about what’s happening in the tissue itself, at a level routine pathology was never built to see.
What a biopsy is actually built to catch
When a gastroenterologist takes a tissue sample, it goes to a pathologist who stains it with a standard dye combination and looks for a specific, well-defined list: ulceration, cancerous or precancerous cells, celiac-pattern damage, visible inflammatory cell infiltration consistent with inflammatory bowel disease. That’s the job the stain is designed for, and it does that job well.
What it isn’t designed to count, under a routine stain, is a specific immune cell called a mast cell, or where those mast cells sit relative to the nerve endings running through the gut wall. Counting that requires a different kind of stain entirely, immunohistochemistry, that targets a marker called tryptase inside the cell. It’s not part of a standard biopsy workup. Nobody’s cutting a corner by skipping it. It’s simply not what the routine test looks for.
Think of it as two entirely different questions asked of the same exact piece of tissue. The routine stain asks: is anything visibly broken here? The specialized stain asks: how are the immune cells positioned relative to the nerves? A biopsy report can honestly answer no to the first question while the second question, unasked, would have told a completely different story.
The mast cells sitting on your nerves
Mast cells are immune cells that release histamine, tryptase, and other compounds when activated, part of the body’s normal defense system. Having some present in gut tissue is completely normal and expected. What differs in some women with chronic gut symptoms isn’t just how many are there, but specifically how close they sit to nerve fibers.
A study published in Gastroenterology in 2004 measured this directly in 44 people with IBS and 22 healthy volunteers. Mast cells located within 5 micrometers of a nerve fiber, close enough to directly influence it, averaged 7.14 per field in the IBS group, compared with 2.27 per field in the healthy group. And it was specifically that close-proximity count, not the total mast cell count, that correlated with how severe and how frequent the abdominal pain was.
The mechanism makes sense once you see the numbers: an activated mast cell sitting directly against a nerve ending can release histamine and tryptase right where the nerve can pick up the signal, provoking real, physical pain from tissue that, structurally, under every routine measure, is entirely intact.
A hormone connection that hasn’t been directly tested
Here’s where I have to draw a line between what’s established and what’s a reasonable but unproven connection, because the two get blurred constantly in this space.
Established: mast cells carry estrogen receptors, and a 2007 study in Molecular Immunology found that estradiol activates mast cells directly through a fast-acting estrogen receptor pathway, triggering calcium influx and promoting the same kind of degranulation that releases histamine and tryptase, a separate signaling route from the one that slows gut transit. Progesterone tends to work the other way, stabilizing mast cell membranes rather than triggering them, consistent with its generally calming effect elsewhere in the gut.
Not established: whether the estrogen swings of perimenopause specifically increase mast cell activation near gut nerve endings in a way that’s been measured in this population. Nobody has run that exact study, tracking hormone levels and mast cell proximity in the same women over time. What exists is solid mast cell biology and solid estrogen biology, sitting right next to each other, unconnected by direct research in this specific context. I think the connection is plausible enough to mention. I don’t think it’s fair to present it as proven, and I won’t.
| Routine biopsy | Mast cell / nerve proximity analysis | |
|---|---|---|
| What it stains for | Structural damage, cancer, celiac pattern, visible inflammation | Tryptase-positive mast cells and their distance from nerve fibers |
| Part of standard workup? | Yes | No, requires specialized immunohistochemistry |
| A “normal” result means | No structural or inflammatory disease found | Nothing, since it isn’t measured |
| Where the science stands | Well established, decades of standardization | Established mechanism, but not routinely tested for in clinical practice |
What this looks like in practice
Not a way to order the specialized test yourself, since it isn’t part of routine care and isn’t something you can request casually.
A normal biopsy report is genuinely reassuring about the specific things it checks for. It rules out damage, cancer, and celiac disease, and that’s real, meaningful news. It says nothing at all about mast cell proximity, because that’s not what it was reading.
Pain that persists despite normal structural results has a plausible, published mechanism, not just a “functional” label with no explanation behind it. Knowing that can be its own kind of relief, separate from whatever you decide to actually do about it.
If this research interests you, it’s reasonable to ask your gastroenterologist whether it’s relevant to your case, particularly if pain is a dominant symptom over bloating or bowel habit change specifically. It’s a fair, specific, informed question, not an unusual one, and naming the actual mechanism tends to get a more substantive answer than describing the symptom alone.
Those same cells release histamine, and histamine has a separate disposal problem. An enzyme called DAO clears it, and what happens when specific foods start causing trouble they never used to runs through that route rather than through anything a biopsy stains for. Different mechanism, same frustrating result on the report.
Common questions
If my colonoscopy and biopsy were normal, could I still have a real physical problem?
Yes. Routine biopsies check for structural and inflammatory disease using standard staining. They don’t measure mast cell activity or proximity to nerve fibers, which is a separate, published mechanism for pain in structurally normal tissue.
Can I ask for the specialized mast cell staining?
You can ask, but it isn’t part of routine clinical pathology and isn’t available or appropriate in every case. It’s more commonly used in research settings currently than in standard care.
Is this the same thing as a mast cell activation syndrome diagnosis?
No. This is about localized mast cell behavior in gut tissue specifically, not the broader systemic condition sometimes discussed under that name, which involves a different diagnostic process entirely.
Does this explain why symptoms seem to track with my cycle or with perimenopause?
It’s a plausible connection, since mast cells respond to estrogen directly, but it hasn’t been specifically studied in perimenopausal gut symptoms. I’d rather tell you that gap exists than imply it’s settled.
Why isn’t this test done more often if the mechanism is real?
Cost, specialized processing, and the fact that a positive result doesn’t currently change first-line treatment much. That’s a practical limitation of the healthcare system, not a sign the mechanism isn’t real.
Does this mean my pain is caused by inflammation after all?
Not in the way inflammation usually gets discussed. This isn’t the kind of inflammation a routine biopsy flags, and it isn’t treated with the same medications used for inflammatory bowel disease. It’s a distinct, localized immune-nerve interaction, not a systemic inflammatory disease.
The tissue-level mechanism explains why pain can be real without visible damage. It doesn’t tell you what’s actually worth trying once you know that, and that’s graded honestly, next.
Fortylight is written by Nina Halvorsen, a food scientist, not a physician, dietitian, or licensed health professional. Nothing here is medical advice. Digestive symptoms can signal serious conditions. If you have blood in your stool, unexplained weight loss, persistent vomiting, difficulty swallowing, bleeding after menopause, or symptoms that began after age 50, see a doctor before trying anything on this site.